Podcast episode
Healthcare Company Briefings · 12:20 · 2026-08-04
Oura's executing at an elite level — they're on track for nearly $2 billion in revenue this year, doubling from 2025.
Transcript — free half of this episode
host: Welcome back to AskCyborg — I'm Alex. Today we're digging into Oura Health Oy, the Finnish smart ring maker that basically created this category. With me as always is James, who reads the growth and operating signals, and Sarah, who reads the margins, moat, and execution evidence. Let's get into it.
analyst2: Oura makes a titanium smart ring that tracks sleep, recovery, and readiness, paired with a $5.99 monthly subscription for full insights. They launched the Oura Ring 4 in October 2024 with improved sensor accuracy, and they've been building out an ecosystem — acquiring metabolic health platform Veri in September 2024 and digital identity firm Proxy back in May 2023. With around 600 employees and estimated annual revenue in the $350 to $500 million range, this isn't a niche gadget company anymore — it's a health platform with real recurring revenue behind the hardware.
analyst1: Right, and that subscription layer is the real story. Hardware gets you in the door, but recurring revenue is what proves durability. The bigger question is moat — Samsung launched the Galaxy Ring in July 2024, and you've also got RingConn and Ultrahuman pushing specialized sensors. Oura's had a head start and brand loyalty, but I want to see if that subscription attach rate holds up as the category gets crowded.
analyst2: Fair — and that's exactly why competitive footing matters more than the sensor specs this year. Samsung entering changes the ceiling, not the floor, for Oura. If you want the full picture, unlock the full Oura Health Oy report and complete podcast to hear the assessment, the bull case, the bear case, and the analyst debate behind it — and for context, the Samsung and RingConn reports are worth comparing side by side.
host: Hold up — this is where it gets interesting. One thing worth sitting with: Oura built an entire acquisition strategy around metabolic and identity data, not just ring sensors, and that says a lot about where they think this business is headed. James and Sarah are about to weigh in with their full analysis — leadership, financials, risks, catalysts, all of it. Remember, this is strategic business analysis, not investment advice. The best move is an AskCyborg subscription, which unlocks this full podcast, the complete strategic report, and every other company and industry briefing we produce. If you just want Oura Health Oy, you can unlock the full report and podcast on its own. The full verdict is waiting — let's unlock it.